MedTrace Logo

The Distress-barometer: Face-to-face Interviews or Written Self-report Questionnaires?

NCT03357744 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2017-11-30

No results posted yet for this study

Summary

Breast cancer is the most prevalent cancer among women worldwide \[1\]. 5 years after diagnosis, up to 87% survives. A substantial group of these survivors report reduced physical, psycho social and cognitive functioning. Therefore, it is increasingly important to screen for distress, both during and after treatment. The Distress Barometer (DB) is a valid, short screening instrument, used to detect elevated levels of distress in patients with cancer. It can be used either in a self-report questionnaire or in an interview format.

Although the DB is used in different ways, it remains unclear whether both assessment methods would generate similar results, and which format is most suitable to represent the actual level of distress. Existing literature on the DB lacks a systematic description of the relationship between the method of assessment and the patients' responses. This study questions whether the written and interview variants of the DB reveal different results in the same patients with breast cancer.

Conditions

Interventions

OTHER

distress barometer

not applicable, observational study

Sponsors & Collaborators

  • Ziekenhuis Oost-Limburg

    collaborator OTHER

  • KU Leuven

    lead OTHER

Principal Investigators

  • Marjan van den Akker, PhD · KU Leuven

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-10-31
Completion
2016-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03357744 on ClinicalTrials.gov